SUCCESSFUL RE-TREATMENT WITH AZACITIDINE IN A PATIENT WITH MYELODYSPLASTIC SYNDROME (MDS) EVOLUTED INTO ACUTE MYELOID LEUKEMIA (AML) AFTER THE SUSPENSION OF THIS AGENT

被引：0
|
作者：
Niscola, P. [1 ]
Tendas, A. [1 ]
Cupelli, L. [1 ]
Scaramucci, L. [1 ]
Giovannini, M. [1 ]
Fratoni, S. [2 ]
de Fabritiis, P. [2 ]
机构：
[1] S Eugenio Hosp, Hematol, Rome, Italy
[2] S Eugenio Hosp, Dept Pathol, Rome, Italy
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
274
引用
收藏
页码：S137 / S138
页数：3
相关论文
共 50 条
  • [31] A Patient-Reported Outcome Measure for Symptoms and Symptom Burden of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Garcia-Gonzalez, Araceli
    Ahaneku, Hycienth O.
    Cortes, Jorge E.
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    Mendoza, Tito R.
    Shi, Qiuling
    Borthakur, Gautam
    Burger, Jan A.
    Jabbour, Elias J.
    Takahashi, Koichi
    Lin, Huei K.
    Limaye, Achala
    Cleeland, Charles S.
    BLOOD, 2015, 126 (23)
  • [32] A PATIENT-REPORTED OUTCOME MEASURE FOR SYMPTOMS AND SYMPTOM BURDEN OF ACUTE MYELOID LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROME (MDS).
    Williams, Loretta A.
    Gonzalez, Araceli Garcia
    Cortes, Jorge E.
    Garcia-Manero, Guillermo
    Mendoza, Tito R.
    Cleeland, Charles S.
    ONCOLOGY NURSING FORUM, 2016, 43 (02) : 59 - 60
  • [33] A PHASE I STUDY OF THE COMBINATION OF AZACITIDINE AND ORAL RIGOSERTIB IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) OR ACUTE MYELOID LEUKEMIA (AML)
    Navada, S. C.
    Garcia-Manero, G.
    Hearn, K.
    Odchimar-Reissig, R.
    Demakos, E.
    Alvarado, Y.
    Daver, N.
    DiNardo, C.
    Konopleva, M.
    Borthakur, G.
    Azarnia, N.
    Silverman, L. R.
    LEUKEMIA RESEARCH, 2015, 39 : S45 - S45
  • [34] Results of 5-azacitidine therapy in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)
    Freyrie, A.
    Reda, G.
    Vincenti, D.
    Ferla, V.
    Orofino, N.
    Sciume, M.
    Guidotti, F.
    Cortelezzi, A.
    LEUKEMIA RESEARCH, 2013, 37 : S157 - S158
  • [35] Successful treatment of patients with acute myeloid leukemia and Myelodysplastic Syndrome by decitabine
    Bulbul, Hale
    Davulcu, Eren A.
    Atilla, Fatos D.
    Ulusoy, Yusuf
    Soyer, Nur
    Saydam, Guray
    KUWAIT MEDICAL JOURNAL, 2022, 54 (03): : 385 - 391
  • [36] LOW-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROME (MDS)
    WEH, HJ
    ZSCHABER, R
    HOSSFELD, DK
    BLUT, 1984, 48 (04): : 239 - 242
  • [37] ORAL RIGOSERTIB COMBINED WITH AZACITIDINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROMES (MDS): EFFECTS IN TREATMENT NAIVE AND RELAPSED/REFRACTORY PATIENTS
    Navada, S.
    Garcia-Manero, G.
    Hearn, K.
    Odchimar-Reissig, R.
    Demakos, E.
    Fenaux, P.
    Petrone, M.
    Zbyszewski, P.
    Fruchtman, S.
    Silverman, L.
    HAEMATOLOGICA, 2017, 102 : 183 - 184
  • [38] MYC Expression Is Prognostic in Therapy Related Acute Myeloid Leukemia (AML) and AML with Myelodysplastic Syndrome (MDS)-Related Changes
    Ohanian, Maro
    Rozovski, Uri
    Kantarjian, Hagop M.
    Loghavi, Sanam
    Huh, Yang O.
    Abruzzo, Lynne
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Andreeff, Michael
    Kornblau, Steven M.
    Borthakur, Gautam
    Nguyen, Martin
    Stingo, Francesco
    Hu, Peter
    Fox, Patricia
    Medeiros, L. Jeffrey
    Estrov, Zeev
    Bueso-Ramos, Carlos E.
    Cortes, Jorge E.
    BLOOD, 2014, 124 (21)
  • [39] Hospitalization rates in elderly, newly diagnosed acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) patients treated with azacitidine.
    Ueda, Masumi
    Gupta, Divya
    Caimi, Paolo Fabrizio
    Creger, Richard
    Little, Jane
    William, Basem M.
    Lazarus, Hillard M.
    De Lima, Marcos J. G.
    Cooper, Brenda W.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] MORPHOLOGY OF T(8-21) ACUTE MYELOID-LEUKEMIA MYELODYSPLASTIC SYNDROME (AML/MDS)
    HUTCHISON, R
    LAWRENCE, D
    MACCALLUM, J
    VARNEY, J
    DEHORITY, D
    WURSTERHILL, D
    BLOOMFIELD, C
    DAVEY, F
    LABORATORY INVESTIGATION, 1991, 64 (01) : A74 - A74
12345